Eli Lilly’s Verzenio Picks Up Third Approved Indication Post author:Sam Post published:February 26, 2018 Post category:BioPharma Eli Lilly snagged regulatory approval for expanded use of cancer treatment Verzenio. Source: BioSpace You Might Also Like Novartis AG Boss Updates Q2 Financials and Reaffirms M&A Strategy July 18, 2017 J&J to Spend More on R&D With Tax Reform Money January 23, 2018 4 Biotechs to Make a Move On Now January 23, 2017
